Abbott Point of Care, a subsidiary of Abbott, has received US Food and Drug Administration (FDA) approval for i-STAT 1 Wireless handheld, a new wireless version of the i-STAT point of care testing system.
Abbott Point of Care claimed the new version allows real time transmission of diagnostic test results generated by i-STAT 1 directly from the patient bedside.
The intuitive analyzer needs only two or three drops of blood to provide results.
Blood is added to disposable cartridges that contain test reagents; the cartridge is then inserted in the analyzer; and results are provided in minutes.
i-STAT tests include chemistries, blood gases, electrolytes and tests for lactate, hemoglobin, coagulation and hematology.
i-STAT 1 Wireless handheld is used by clinicians in emergency departments, intensive care units, operating rooms, catheterization labs, outpatient clinics and physician offices.
Abbott head Greg Arnsdorff said with i-STAT 1 Wireless, caregivers are able to share critical test information electronically without leaving the patient’s bedside.
New Jersey-based Abbott Point of Care develops, manufactures and markets critical medical diagnostic and data management products for rapid blood analysis.